IL-4 mediates dicloxacillin-induced liver injury in mice

Toxicology Letters

Volumn 200, Issue 3, 2011, Pages 139-145

  Higuchi, Satonori ^a   Kobayashi, Masanori ^a   Yoshikawa, Yukitaka ^a   Tsuneyama, Koichi ^b   Fukami, Tatsuki ^a   Nakajima, Miki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

13,14 Dihydro 15 keto prostaglandin D2; Drug induced liver injury; IL 4

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; DICLOXACILLIN; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN D2; RECOMBINANT INTERLEUKIN 4; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT1 PROTEIN; STAT3 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HELPER CELL; LIVER INJURY; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ALANINE TRANSAMINASE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BLOCKING; BILIRUBIN; DICLOXACILLIN; DRUG-INDUCED LIVER INJURY; FEMALE; INTERLEUKIN-4; LIVER; MICE; MICE, INBRED BALB C; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, HELPER-INDUCER; TH2 CELLS;

ANIMALIA; MUS;

EID: 78651090716     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.11.006     Document Type: Article

References (30)

1. Biedermann B.T., Knelling M., Mailhammer R., Maier K., Sander C.A., Kollias G., Kunkel S.L., Hultner L., Rocken M. Mast cell control neutrophil recruitment during T cell-mediated delayed hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 2000, 192:1441-1451.
2. Bjornsson E., Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005, 42:481-489.
3. Daly A.K., Donaldson P.T., Bhatnagar P., et al. HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 2009, 41:816-819.
4. Dambach D.M., Durham S.K., Laskin J.D., Laskin D.L. Distinct roles of NF-κB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol. Appl. Pharmacol. 2006, 211:157-165.
5. Gaestel M., Kotlyarov A., Kracht M. Targeting innate immunity protein kinase signaling in inflammation. Nat. Rev. Drug. Discov. 2009, 8:480-497.
6. Harada K., Water J.V., Leung P.S.C., Coppel R.L., Ansari A., Nakanuma Y., Gershwin M.E. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997, 25:791-796.
7. Heneghan M.A., McFarlane I.G. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002, 35:7-13.
8. Holt M.P., Ju C. Mechanisms of drug-induced liver injury. AAPS J. 2006, 8:48-54.
9. Jaruga B., Hong F., Sun R., Radaeva S., Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J. Immunol. 2003, 171:3233-3244.
10. Kato A., Yoshidome H., Edwards M.J., Lentsch A.B. Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6. Inflamm. Res. 2000, 49:275-279.
11. Kay A.B. Allergy and allergic diseases. N. Engl. J. Med. 2001, 344:30-37.
12. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003, 8:223-246.
13. Kita H., Macky I.R., Van D.W.J., Gershwin M.E. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001, 120:1485-1501.
14. Kobayashi E., Kobayashi M., Tsuneyama K., Fukami T., Nakajima M., Yokoi T. Halothane-induced liver injury is mediated by interleukin-17 in mice. Toxicol. Sci. 2009, 111:302-310.
15. Kostenis E., Ulven T. Emerging roles of DP and CRTh2 in allergic inflammation. Trends Mol. Med. 2006, 12:148-158.
16. Kumada T., Tsuneyama K., Hatta H., Ishizawa S., Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod. Pathol. 2004, 17:1141-1149.
17. Leonard W.J., O'Shea J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 1998, 16:293-322.
18. 2 enhances allyl alcohol-induced toxicity in rat hepatocytes. Toxicol. Sci. 2004, 77:290-298.
19. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signaling mechanisms biologic functions. Annu. Rev. Immunol. 1999, 17:701-738.
20. Njoku D.B., Li Z., Washington N.D., Mellerson J.L., Talor M.V., Sharma R., Rose N.R. Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury. Eur. J. Immunol. 2009, 39:1652-1663.
21. Olsson R., Wiholm B.E., Sand C., Zettergren L., Hultcrantz R., Myehed M. Liver damage from flucloxacillin, cloxacillin, dicloxacillin. J. Hepatol. 1992, 15:154-161.
22. Palmer C.D., Restifo P.N. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol. 2009, 30:592-602.
23. Reilly T.P., Brady J.N., Marchick M.R., Bourdi M., George J.W., Radonovich M.F., Pise-Masison C.A., Pohl L.R. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem. Res. Toxicol. 2001, 14:1620-1628.
24. Shaw P.J., Ditewig A.C., Waring J.F., Liguori M.J., Blomme E.A., Ganey P.E., Roth R.A. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. Toxicol. Sci. 2009, 107:270-280.
25. Spanakis N.E., Garinis G.A., Alexopoulos E.C., Patrinos G.P., Menounos P.G., Sklavounou A., Manolis N.E., Gorgoulis V.G., Valis D. Cytokines serum levels in patients with chronic HCV infection. J. Clin. Lab. Anal. 2002, 16:40-46.
26. 2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J. Immunol. 2005, 174:3703-3708.
27. Stein G.E. Safety of newer parenteral antibiotics. Clin. Infect. Dis. 2005, 41:293-302.
28. Steinman L. A brief history of Th17, the first major revision in the Th1/Th2 hypothesis if T cell-mediated tissue damage. Nat. Rev. Med. 2007, 13:139-145.
29. Takeshita K., Yamasaki T., Nagano K., Sugimoto H., Shichijo M., Gantner F., Bacon B.K. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int. Immunol. 2004, 16:947-959.
30. Zou W., Devi S.S., Sparkenbaugh E., Younis H.S., Roth R.A., Ganey P.E. Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system. Toxicol. Sci. 2009, 108:184-193.